Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ICOSAPENT vs IDELALISIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ICOSAPENT vs IDELALISIB: Safety Overview

Metric ICOSAPENT IDELALISIB
Total FAERS Reports 123 6,862
Deaths Reported 4 1,548
Death Rate 3.3% 22.6%
Hospitalizations 87 2,962
Average Patient Age 50.0 yrs 70.0 yrs
% Female Patients 50.4% 38.4%
FDA Approval Date N/A Jul 23, 2014
Manufacturer N/A Gilead Sciences, Inc.
Route N/A ORAL
Marketing Status N/A Prescription